160 related articles for article (PubMed ID: 9616134)
21. Identification and functional characterization of imatinib-sensitive DTD1-PDGFRB and CCDC88C-PDGFRB fusion genes in eosinophilia-associated myeloid/lymphoid neoplasms.
Gosenca D; Kellert B; Metzgeroth G; Haferlach C; Fabarius A; Schwaab J; Kneba M; Scheid C; Töpelt K; Erben P; Haferlach T; Cross NC; Hofmann WK; Seifarth W; Reiter A
Genes Chromosomes Cancer; 2014 May; 53(5):411-21. PubMed ID: 24772479
[TBL] [Abstract][Full Text] [Related]
22. Trisomy 8 in PDGFRB-negative cells in a patient with imatinib-sensitive chronic myelomonocytic leukemia and t(5;16)(q33;p13), PDGFRB-NDE1 fusion.
Cavazzini F; Bardi A; Ciccone M; Rigolin GM; Gorello P; La Starza R; Mecucci C; Cuneo A
Cancer Genet Cytogenet; 2009 Oct; 194(1):67-9. PubMed ID: 19737658
[No Abstract] [Full Text] [Related]
23. Myeloproliferative disorders with translocations of chromosome 5q31-35: role of the platelet-derived growth factor receptor Beta.
Steer EJ; Cross NC
Acta Haematol; 2002; 107(2):113-22. PubMed ID: 11919393
[TBL] [Abstract][Full Text] [Related]
24. Huntingtin interacting protein 1 Is a clathrin coat binding protein required for differentiation of late spermatogenic progenitors.
Rao DS; Chang JC; Kumar PD; Mizukami I; Smithson GM; Bradley SV; Parlow AF; Ross TS
Mol Cell Biol; 2001 Nov; 21(22):7796-806. PubMed ID: 11604514
[TBL] [Abstract][Full Text] [Related]
25. Involvement of the TEL gene in hematologic malignancy by diverse molecular genetic mechanisms.
Golub TR; Barker GF; Stegmaier K; Gilliland DG
Curr Top Microbiol Immunol; 1996; 211():279-88. PubMed ID: 8585959
[No Abstract] [Full Text] [Related]
26. Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta.
Apperley JF; Gardembas M; Melo JV; Russell-Jones R; Bain BJ; Baxter EJ; Chase A; Chessells JM; Colombat M; Dearden CE; Dimitrijevic S; Mahon FX; Marin D; Nikolova Z; Olavarria E; Silberman S; Schultheis B; Cross NC; Goldman JM
N Engl J Med; 2002 Aug; 347(7):481-7. PubMed ID: 12181402
[TBL] [Abstract][Full Text] [Related]
27. Novel translocations that disrupt the platelet-derived growth factor receptor beta (PDGFRB) gene in BCR-ABL-negative chronic myeloproliferative disorders.
Baxter EJ; Kulkarni S; Vizmanos JL; Jaju R; Martinelli G; Testoni N; Hughes G; Salamanchuk Z; Calasanz MJ; Lahortiga I; Pocock CF; Dang R; Fidler C; Wainscoat JS; Boultwood J; Cross NC
Br J Haematol; 2003 Jan; 120(2):251-6. PubMed ID: 12542482
[TBL] [Abstract][Full Text] [Related]
28. The Tel-PDGFRbeta fusion gene produces a chronic myeloproliferative syndrome in transgenic mice.
Ritchie KA; Aprikyan AA; Bowen-Pope DF; Norby-Slycord CJ; Conyers S; Bartelmez S; Sitnicka EH; Hickstein DD
Leukemia; 1999 Nov; 13(11):1790-803. PubMed ID: 10557054
[TBL] [Abstract][Full Text] [Related]
29. Novel MLL-CBP fusion transcript in therapy-related chronic myelomonocytic leukemia with a t(11;16)(q23;p13) chromosome translocation.
Satake N; Ishida Y; Otoh Y; Hinohara S; Kobayashi H; Sakashita A; Maseki N; Kaneko Y
Genes Chromosomes Cancer; 1997 Sep; 20(1):60-3. PubMed ID: 9290955
[TBL] [Abstract][Full Text] [Related]
30. Evidence for a role of NF-kappaB in the survival of hematopoietic cells mediated by interleukin 3 and the oncogenic TEL/platelet-derived growth factor receptor beta fusion protein.
Besançon F; Atfi A; Gespach C; Cayre YE; Bourgeade MF
Proc Natl Acad Sci U S A; 1998 Jul; 95(14):8081-6. PubMed ID: 9653143
[TBL] [Abstract][Full Text] [Related]
31. The TEL gene contributes to the pathogenesis of myeloid and lymphoid leukemias by diverse molecular genetic mechanisms.
Golub TR; Barker GF; Stegmaier K; Gilliland DG
Curr Top Microbiol Immunol; 1997; 220():67-79. PubMed ID: 9103676
[No Abstract] [Full Text] [Related]
32. A new NDE1/PDGFRB fusion transcript underlying chronic myelomonocytic leukaemia in Noonan Syndrome.
La Starza R; Rosati R; Roti G; Gorello P; Bardi A; Crescenzi B; Pierini V; Calabrese O; Baens M; Folens C; Cools J; Marynen P; Martelli MF; Mecucci C; Cuneo A
Leukemia; 2007 Apr; 21(4):830-3. PubMed ID: 17301821
[No Abstract] [Full Text] [Related]
33. The coupling of TEL/PDGFbetaR to distinct functional responses is modulated by the presence of cytokine: involvement of mitogen-activated protein kinases.
Wheadon H; Welham MJ
Blood; 2003 Aug; 102(4):1480-9. PubMed ID: 12714513
[TBL] [Abstract][Full Text] [Related]
34. Molecular cytogenetic findings in a four-way t(1;12;5;12)(p36;p13;q33;q24) underlying the ETV6-PDGFRB fusion gene in chronic myelomonocytic leukemia.
Crescenzi B; La Starza R; Nozzoli C; Ciolli S; Matteucci C; Romoli S; Rigacci L; Gorello P; Bosi A; Martelli MF; Marynen P; Mecucci C
Cancer Genet Cytogenet; 2007 Jul; 176(1):67-71. PubMed ID: 17574967
[TBL] [Abstract][Full Text] [Related]
35. Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia.
Golub TR; Barker GF; Bohlander SK; Hiebert SW; Ward DC; Bray-Ward P; Morgan E; Raimondi SC; Rowley JD; Gilliland DG
Proc Natl Acad Sci U S A; 1995 May; 92(11):4917-21. PubMed ID: 7761424
[TBL] [Abstract][Full Text] [Related]
36. HIP1-ALK, a novel ALK fusion variant that responds to crizotinib.
Fang DD; Zhang B; Gu Q; Lira M; Xu Q; Sun H; Qian M; Sheng W; Ozeck M; Wang Z; Zhang C; Chen X; Chen KX; Li J; Chen SH; Christensen J; Mao M; Chan CC
J Thorac Oncol; 2014 Mar; 9(3):285-94. PubMed ID: 24496003
[TBL] [Abstract][Full Text] [Related]
37. The t(8;13)(p11;q11-12) rearrangement associated with an atypical myeloproliferative disorder fuses the fibroblast growth factor receptor 1 gene to a novel gene RAMP.
Smedley D; Hamoudi R; Clark J; Warren W; Abdul-Rauf M; Somers G; Venter D; Fagan K; Cooper C; Shipley J
Hum Mol Genet; 1998 Apr; 7(4):637-42. PubMed ID: 9499416
[TBL] [Abstract][Full Text] [Related]
38. RET fusion genes are associated with chronic myelomonocytic leukemia and enhance monocytic differentiation.
Ballerini P; Struski S; Cresson C; Prade N; Toujani S; Deswarte C; Dobbelstein S; Petit A; Lapillonne H; Gautier EF; Demur C; Lippert E; Pages P; Mansat-De Mas V; Donadieu J; Huguet F; Dastugue N; Broccardo C; Perot C; Delabesse E
Leukemia; 2012 Nov; 26(11):2384-9. PubMed ID: 22513837
[TBL] [Abstract][Full Text] [Related]
39. Huntingtin interacting protein 1 is a novel brain tumor marker that associates with epidermal growth factor receptor.
Bradley SV; Holland EC; Liu GY; Thomas D; Hyun TS; Ross TS
Cancer Res; 2007 Apr; 67(8):3609-15. PubMed ID: 17440072
[TBL] [Abstract][Full Text] [Related]
40. ARG tyrosine kinase activity is inhibited by STI571.
Okuda K; Weisberg E; Gilliland DG; Griffin JD
Blood; 2001 Apr; 97(8):2440-8. PubMed ID: 11290609
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
